(Q51491433)

5 April 2018

title

Bone marrow plasminogen activator inhibitor-1 influences the development of obesity. (English)

1 reference

5 April 2018

0 references

1 reference

Bart M De Taeye

1

1 reference

5 April 2018

Tatiana Novitskaya

2

1 reference

5 April 2018

Linda Gleaves

3

1 reference

5 April 2018

Joseph W Covington

4

1 reference

5 April 2018

Douglas E Vaughan

5

1 reference

5 April 2018

language of work or name

English

0 references

publication date

23 August 2006

1 reference

5 April 2018

Journal of Biological Chemistry

published in

1 reference

5 April 2018

volume

281

1 reference

5 April 2018

issue

43

1 reference

5 April 2018

page(s)

32796-32805

1 reference

5 April 2018

Pleiotropic functions of plasminogen activator inhibitor-1.

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Changes in leptin, plasminogen activator factor and oxidative stress in morbidly obese patients following open and laparoscopic Swedish adjustable gastric banding

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Prevention of obesity and insulin resistance in mice lacking plasminogen activator inhibitor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Age-dependent spontaneous coronary arterial thrombosis in transgenic mice that express a stable form of human plasminogen activator inhibitor-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Distribution and regulation of plasminogen activator inhibitor-1 in murine adipose tissue in vivo. Induction by tumor necrosis factor-alpha and lipopolysaccharide

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Angiotensin II and its metabolites stimulate PAI-1 protein release from human adipocytes in primary culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Tumor necrosis factor alpha is a key component in the obesity-linked elevation of plasminogen activator inhibitor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Tissue- and agonist-specific regulation of human and murine plasminogen activator inhibitor-1 promoters in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Leptin: a metabolic hormone that functions like a proinflammatory adipokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Plasminogen activator inhibitor-1 represses integrin- and vitronectin-mediated cell migration independently of its function as an inhibitor of plasminogen activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Plasminogen activator inhibitor-1 and -3 increase cell adhesion and motility of MDA-MB-435 breast cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin. Implications for antiangiogenic strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

The pro- or antiangiogenic effect of plasminogen activator inhibitor 1 is dose dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Dose-dependent modulation of choroidal neovascularization by plasminogen activator inhibitor type I: implications for clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

Production of Plasminogen Activator Inhibitor 1 by Human Adipose Tissue: Possible Link Between Visceral Fat Accumulation and Vascular Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M606214200

21 January 2018

Identifiers

DOI

10.1074/JBC.M606214200

1 reference

5 April 2018

PubMed ID

16931518

1 reference

5 April 2018